Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...

This is also true for the sector’s IPO market. Compared to 2021, when many biotech IPOs were pre-clinical, sector IPOs today are more likely to be at the matured clinical stage, anticipating a ...

Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

The biotech is developing two candidates ... Another slice of the targeted IPO haul is earmarked for a proof-of-concept trial of F598, Alopexx’s other lead candidate. Sanofi licensed the ...

Belrise Industries aims to raise Rs 2,150 crore, while Paramesu Biotech plans to mop up Rs 600 crore through the public issue. Sebi had received their preliminary IPO documents in November and issued ...

Many experts - be they venture capitalists or private equity investprs - shared their advice to biotech entrepreneurs navigating a tough funding envornment.

IPO Watch: Allchem Lifescience Limited has ... Hattori Corporation, Huaian Jiamu Biotechnology Co. Ltd, Indoco Remedies Ltd, Megafine Pharma (P) Ltd, Micro Labs Ltd, Moehs Iberica, S.L., MSN ...

Belrise Industries and Paramesu Biotech have received market regulator, Securities and Exchange Board of India's (SEBI) go ahead to raise funds totalling `2,750 Crore through Initial Public Offerings ...